Internal Medicine · Monrovia, CA
NPI
1730392655
Since 2007
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
831 E Huntington Dr Ste 101
Monrovia, CA, 91016
Phone (626) 358-0269
Groups this clinician bills Medicare through
Medicare paid, 2024
$9,411
207 services
Medicare patients, 2024
45
Average age 74
Drug cost, 2024
$1.3M
3,508 prescriptions
Company payments, 2025
$48.8
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nandar M Swe was code 99214 (office e&m - established), 65 times for 34 patients. In total Nandar M Swe billed 207 services in 9 codes, and Medicare paid $9,411.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-01-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 65 | 34 | $95.40 | $6,201 |
By year: 2022 $13K for 305 services; 2023 $11K for 228 services; 2024 $9,411 for 207 services.
Medicare prescription drug claims, 2024
In 2024, the drug Nandar M Swe prescribed most often to Medicare patients was Levothyroxine Sodium, with 357 prescriptions and refills. In total Nandar M Swe wrote 3,508 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 357 | 1,026 | 109 | $4,745 |
| Ozempic Semaglutide | 237 | 350 | 49 | $327K |
| Metformin Hcl Er Metformin Hcl | 195 | 525 | 66 | $3,328 |
| Metformin Hcl Generic | 167 | 489 | 56 | $1,786 |
| Glimepiride Generic | 142 | 416 | 51 | $2,167 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 133 | 378 | 58 | $15K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 93 | 269 | 30 | $17K |
| Pioglitazone Hcl Generic | 88 | 246 | 30 | $1,713 |
| Glipizide Generic | 84 | 240 | 29 | $1,629 |
| Atorvastatin Calcium Generic | 78 | 236 | 27 | $870 |
| Amlodipine Besylate Generic | 75 | 193 | 25 | $333 |
| Trulicity Dulaglutide | 70 | 93 | 21 | $90K |
| Tresiba Flextouch U-100 Insulin Degludec | 68 | 196 | 27 | $60K |
| Januvia Sitagliptin Phosphate | 67 | 153 | 21 | $82K |
| Humalog Mix 50-50 Kwikpen Insulin Lispro Protamin/Lispro | 58 | 144 | 22 | $29K |
Brand drugs: 1,369 claims; generic drugs: 1,911 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nandar M Swe $48.8 ($48.8 in general payments such as food, travel and fees) from 1 company. The largest payer was Corcept Therapeutics with $48.8.
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics CORT | 2 | $48.8 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.